| Kim Hoa Tram, PHARMD | |
|
4175 Vinewood Ln N, Plymouth, MN 55442-2624 | |
| (763) 553-1757 | |
| Not Available |
| Full Name | Kim Hoa Tram |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4175 Vinewood Ln N, Plymouth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144515370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 177611 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kim Hoa Tram, PHARMD 4963 Archer Ln N, Plymouth, MN 55446-2744 Ph: (763) 350-4342 | Kim Hoa Tram, PHARMD 4175 Vinewood Ln N, Plymouth, MN 55442-2624 Ph: (763) 553-1757 |
News Archive
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.
Eureka Genomics today announced the closing of a $3.7 million private financing round whose participants included private individuals and undisclosed angel investors. The proceeds will further discovery research aimed at identifying novel microorganisms associated with specific cancers and other important diseases, as well as help grow Eureka Genomics' high-throughput sequencing and bioinformatics service business on a global basis.
West Virginia's redesigned Medicaid program is restricting benefits for more than 90% of child beneficiaries because of insufficient efforts by the state to enroll children in an expanded plan, according to a report released Thursday, the Charleston Gazette reports.
› Verified 3 days ago
Mr. Owen W Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4445 N. Nathan Lane, Plymouth, MN 55442 Phone: 763-557-0377 | |
Mr. Nathan A Holmquist, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6025 Shenandoah Ln N, Plymouth, MN 55446 Phone: 763-252-1300 Fax: 763-252-1306 | |
Olivia F Bachmeier, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4175 Vinewood Ln N, Plymouth, MN 55442 Phone: 763-553-1757 | |
Mrs. Janna Fine Kenigsberg, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5035 Garland Ln N Apt C, Plymouth, MN 55446 Phone: 612-741-8425 | |
Sheri Thompson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4175 Vinewood Ln N, Plymouth, MN 55442 Phone: 763-553-1757 | |
Alahna Anderson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4140 County Road 101 N, Plymouth, MN 55446 Phone: 763-478-4612 | |
Mrs. Rachelle Hemmer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6055 Nathan Ln N, Suite 200a, Plymouth, MN 55442 Phone: 763-463-4400 |